Ardelyx | ARDX - Saham

Keuangan

USD

USD 504.51M

USD 31.21M

Biaya Penjualan

USD 4.81M

USD 381.87M

Kewajiban Lancar

USD 109.57M

USD 208.26M

USD -30.68M

USD -29.77M

395

Eps Laba Per Saham

USD -0.15

Modal Dan Cadangan

USD 148.62M

Laba Kotor Pada Penjualan

USD 89.66M

Beban Bunga Utang

USD 5.6M

USD 203.52M

Kapitalisasi Pasar

USD 863.3M

Batas Pemasukan

USD -37.61M

Biaya Operasional

USD 127.27M

Laba Operasional

USD -32.79M

Modal Saham Biasa

USD 246.97M

Laba Sebelum Pajak

USD -37.6M

Pendapatan Penjualan

USD 94.47M

Beban Penjualan Dan Administrasi

USD 102.27M

USD 128.03M

Kreditur Perdagangan

USD 28.2M

Debitur Perdagangan

USD 82.84M

	Saham	Perubahan		Tanggal
Abbott	USD 6.99B		501M	2026-03
Amgen	USD 6.22B		34M	2026-06
Ardelyx	USD 128.02M		110.29M	2026-03
aTyr Pharma	USD 2.79M		67.83K	2026-03
Corcept Therapeutics	USD 13.18M		295K	2026-06
Sanofi	EUR 23.5B		812M	2026-03
TG Therapeutics	USD 147.97M		18.94M	2026-06
United Therapeutics	USD 193.8M		15.5M	2026-06